For example, Temozolomide, a DNA alkylating agent, is very effective for the treatment of primary glioma, but suffers from MDR due to the DNA repair function of O6-methylguanine methyltransferase (MGMT). This evidence concerns the gene MGMT and central nervous system cancer.